Doxorubicin NEW

Doxorubicin has a wide anti-tumor spectrum and is suitable for acute leukemia (lymphocytic and granulocytic), malignant lymphoma, breast cancer, bronchogenic lung cancer (undifferentiated small cell and non small cell), ovarian cancer, soft tissue sarcoma, osteosarcoma, rhabdomyosarcoma, Ewing sarcoma, blastoma, neuroblastoma, bladder cancer cancer, thyroid cancer, prostate cancer, head and neck squamous cell carcinoma, testicular cancer, gastric cancer, liver cancer, etc.

Application&Function

Adriamycin is an anti-tumor antibiotic that can inhibit the synthesis of RNA and DNA. It has the strongest inhibitory effect on RNA, has a broad anti-tumor spectrum, and has effects on a variety of tumors. It is a cyclic nonspecific drug that has a killing effect on tumor cells in various growth cycles. It is mainly applicable to acute leukemia, and is effective for both acute lymphocytic leukemia and myelocytic leukemia. It is generally used as a second-line drug, which can be considered for use when the preferred drug is resistant.